PCSA logo

Processa Pharmaceuticals (PCSA) Long Term Debt

Annual Long Term Debt

$66.90 K
-$83.70 K-55.58%

December 31, 2023


Summary


Performance

PCSA Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPCSAbalance sheetmetrics:

Quarterly Long Term Debt

$2200.00
-$23.40 K-91.41%

September 30, 2024


Summary


Performance

PCSA Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPCSAbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

PCSA Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-55.6%-95.7%
3 y3 years-45.7%-98.5%
5 y5 years+100.0%-98.5%

PCSA Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-55.6%+804.0%-98.7%at low
5 y5-year-55.6%+804.0%-98.9%at low
alltimeall time-97.0%-100.0%-99.9%-100.0%

Processa Pharmaceuticals Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$2200.00(-91.4%)
Jun 2024
-
$25.60 K(-49.5%)
Mar 2024
-
$50.70 K(-24.2%)
Dec 2023
$66.90 K(-55.6%)
$66.90 K(-24.7%)
Sep 2023
-
$88.80 K(-18.8%)
Jun 2023
-
$109.30 K(-15.5%)
Mar 2023
-
$129.40 K(-14.1%)
Dec 2022
$150.60 K(+1935.1%)
$150.60 K(-12.3%)
Sep 2022
-
$171.70 K(+3553.2%)
Jun 2022
-
$4700.00(-23.0%)
Mar 2022
-
$6100.00(-17.6%)
Dec 2021
$7400.00(-94.0%)
$7400.00(-15.9%)
Sep 2021
-
$8800.00(-71.5%)
Jun 2021
-
$30.90 K(-52.5%)
Mar 2021
-
$65.00 K(-47.3%)
Dec 2020
$123.30 K(-16.4%)
$123.30 K(-22.4%)
Sep 2020
-
$158.90 K(-22.4%)
Jun 2020
-
$204.90 K(+59.8%)
Mar 2020
-
$128.20 K(-13.0%)
DateAnnualQuarterly
Dec 2019
$147.40 K(>+9900.0%)
$147.40 K(-11.6%)
Sep 2019
-
$166.70 K(-10.7%)
Jun 2019
-
$186.70 K(-17.2%)
Mar 2019
-
$225.40 K(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2015
-
$27.50 K(-73.8%)
Jun 2015
-
$104.90 K(-12.1%)
Mar 2015
-
$119.40 K(-75.8%)
Dec 2014
$494.10 K(+239.6%)
$494.10 K(-75.0%)
Sep 2014
-
$1.97 M(+23.4%)
Jun 2014
-
$1.60 M(+46.3%)
Mar 2014
-
$1.09 M(+651.5%)
Dec 2013
$145.50 K(-76.0%)
$145.50 K(-6.9%)
Sep 2013
-
$156.20 K(+69.2%)
Jun 2013
-
$92.30 K(-73.6%)
Mar 2013
-
$349.20 K(-42.4%)
Dec 2012
$606.20 K(-72.4%)
$606.20 K(-45.6%)
Sep 2012
-
$1.11 M
Dec 2011
$2.20 M
-

FAQ

  • What is Processa Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Processa Pharmaceuticals?
  • What is Processa Pharmaceuticals annual long term debt year-on-year change?
  • What is Processa Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Processa Pharmaceuticals?
  • What is Processa Pharmaceuticals quarterly long term debt year-on-year change?

What is Processa Pharmaceuticals annual long term debt?

The current annual long term debt of PCSA is $66.90 K

What is the all time high annual long term debt for Processa Pharmaceuticals?

Processa Pharmaceuticals all-time high annual long term debt is $2.20 M

What is Processa Pharmaceuticals annual long term debt year-on-year change?

Over the past year, PCSA annual long term debt has changed by -$83.70 K (-55.58%)

What is Processa Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of PCSA is $2200.00

What is the all time high quarterly long term debt for Processa Pharmaceuticals?

Processa Pharmaceuticals all-time high quarterly long term debt is $1.97 M

What is Processa Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, PCSA quarterly long term debt has changed by -$48.50 K (-95.66%)